Vericel News Timeline Breakdown

VCEL -- USA Stock  

USD 14.80  0.70  4.96%

This is yet another view into Vericel filtered headlines to help investors concentrate on Vericel Corporation noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vericel headlines in addition to utilizing other more conventional financial analysis modules. Also please take a look at Vericel Backtesting and Vericel Hype Analysis.
news
September 6, 2018
Exercise or conversion by Steven Gilman of 9000 shares of Vericel subject to Rule 16b-3 at www.nysetradingnews.com 
View Story
Macroaxis News
September 10, 2018
Exercise or conversion by Dominick Colangelo of 27500 shares of Vericel subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
September 14, 2018
Investors Trading Alert Vericel Corporation at www.talktraders.com 
View Story
Macroaxis News
September 5, 2018
Amgen exotic insider transaction detected at MacroaxisInsider 
View Story
businessinsider News
September 21, 2018
Ontario becomes first province to provide public funding of TRESIBA for adults with diabetes mellitus at markets.businessinsider.com 
View Story
news
September 17, 2018
Glenmark Pharma gets final USFDA nod for menopause symptom relief drug at www.business-standard.com 
View Story
Macroaxis News
September 7, 2018
Sale by Gregg Alton of 3600 shares of Gilead Sciences at MacroaxisInsider 
View Story
seekingalpha News
September 14, 2018
Sale by Toole John J of 100 shares of Gilead Sciences at seekingalpha.com 
View Story
Macroaxis News
September 7, 2018
Exercise or conversion by Adelman Burt A of 20500 shares of Biogen subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
September 13, 2018
Biogen Inc Shares Sold by Bronfman EL Rothschild LP at www.mareainformativa.com 
View Story
news
September 20, 2018
Why this stock is less risky Biogen Inc. at www.wallstreetinvestorplace.com 
View Story
fool News
September 13, 2018
This expert believes ASX market darlings can rally further before the bubble pops at www.fool.com.au 
View Story
news
September 7, 2018
Celgene exotic insider transaction detected at stocknewsgazette.com 
View Story
news
September 11, 2018
797 Large Investors Shied Away From Celgene Corporation at postanalyst.com 
View Story
news
September 17, 2018
Rolling Stocks Celgene Corporation, , Allegheny Technologies Incorporated, at www.nysetradingnews.com 
View Story
seekingalpha News
September 4, 2018
Sutro Biopharma Begins US IPO Effort at seekingalpha.com 
View Story
news
September 4, 2018
Shire plc Snapshot of Recent Traded Stock at www.talktraders.com 
View Story
news
September 18, 2018
Shire plc Rule 2.9 Announcement at globenewswire.com 
View Story
news
August 31, 2018
Equity Review Investors Keen on Shares of Shire plc as it Makes Headlines With Moves at www.thecoinguild.com 
View Story
Macroaxis News
September 6, 2018
Acquisition by Bruce Sachs of 5295 shares of Vertex Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
September 20, 2018
Analyst Stock Ratings General Dynamics Corporation , Vertex Pharmaceuticals Incorporated at www.thewellesleysnews.com 
View Story
Macroaxis News
August 31, 2018
Exercise or conversion by Christopher Fenimore of tradable shares of Regeneron Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
September 12, 2018
Did An Insider Sell Their Shares In BioMarin Pharmaceutical Inc at simplywall.st 
View Story
news
September 18, 2018
Sale by Davis George Eric of 616 shares of BioMarin Pharmaceutical at nysedaily.com 
View Story
Macroaxis News
September 5, 2018
Exercise or conversion by Robert Baffi of 1110 shares of BioMarin Pharmaceutical subject to Rule 16b-3 at MacroaxisInsider 
View Story

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Insider Screener

Also Currentnly Active

Purchased a lot of shares of
3 days ago
Traded for 156.0
Purchased a lot of shares of
3 days ago
Traded for 156.0
Purchased over 300 shares of
3 days ago
Traded for 9.81
Also please take a look at Vericel Backtesting and Vericel Hype Analysis. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com